LINCOLN PHARMACEUTICALS
Back to Cashflow Statement
|
LINCOLN PHARMACEUTICALS Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Investing Activities | ₹-57 Cr | ₹-37 Cr | ₹-78 Cr | ₹-64 Cr | ₹-31 Cr |
What is the latest Cash Flow from Investing Activities ratio of LINCOLN PHARMACEUTICALS ?
Year | Cash Flow from Investing Activities |
---|---|
Mar2024 | ₹-57 Cr |
Mar2023 | ₹-37 Cr |
Mar2022 | ₹-78 Cr |
Mar2021 | ₹-64 Cr |
Mar2020 | ₹-31 Cr |
How is Cash Flow from Investing Activities of LINCOLN PHARMACEUTICALS Trending?
Years | Cash Flow from Investing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-57 Cr | Negative | |
Mar2023 | ₹-37 Cr | Negative | |
Mar2022 | ₹-78 Cr | Negative | |
Mar2021 | ₹-64 Cr | Negative | |
Mar2020 | ₹-31 Cr | - |
Compare Cash Flow from Investing Activities of peers of LINCOLN PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LINCOLN PHARMACEUTICALS | ₹1,536.0 Cr | -8.1% | -16.5% | 26.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹418,936.0 Cr | -5.8% | -3.2% | 35.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹152,157.0 Cr | -2.8% | -3.6% | 44.7% | Stock Analytics | |
CIPLA | ₹116,200.0 Cr | -3.9% | -0.5% | 13.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹111,325.0 Cr | -1.2% | 7.1% | 17.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹98,037.4 Cr | -2.7% | -0.1% | 40.9% | Stock Analytics |
LINCOLN PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LINCOLN PHARMACEUTICALS | -8.1% |
-16.5% |
26.3% |
SENSEX | -2.1% |
-6.4% |
7% |
You may also like the below Video Courses